Table 2.
Linear regression models for 1- and 5-year VRR.
| 1-year volume reduction ratio | |||||||
|---|---|---|---|---|---|---|---|
| Univariate linear regression | Multivariate linear regression | ||||||
| Beta | SE | p-value | Beta | SE | p-value | ||
| Age (years) | -0.002 | 0.002 | 0.15 | // | |||
| Sex | Male | -0.07 | 0.05 | 0.21 | // | ||
| Baseline volume (ml) | -0.003 | 0.002 | 0.06 | -0.001 | 0.001 | 0.27 | |
| Nodule structure | PC | 0.14 | 0.06 | 0.01 | 0.11 | 0.04 | 0.007 |
| PS | 0.01 | 0.05 | 0.82 | 0.04 | 0.03 | 0.29 | |
| Nodule function | Non-AFTN | 0.06 | 0.05 | 0.21 | // | ||
| IAR | 0.005 | 0.006 | <0.001 | 0.004 | 0.0007 | <0.001 | |
| 5-year volume reduction ratio | |||||||
| Univariate linear regression | Multivariate linear regression | ||||||
| Beta | SE | p-value | Beta | SE | p-value | ||
| Age (years) | -0.002 | 0.002 | 0.38 | // | |||
| Sex | Male | 0.02 | 0.07 | 0.72 | // | ||
| Baseline volume (ml) | 0.0001 | 0.002 | 0.95 | // | |||
| Nodule structure | PC | 0.09 | 0.07 | 0.18 | |||
| PS | 0.02 | 0.06 | 0.80 | // | |||
| Nodule function | Non-AFTN | 0.03 | 0.06 | 0.64 | |||
| IAR | 0.005 | 0.001 | <0.001 | 0.005 | 0.001 | <0.001 | |
| Therapeutic efficacy | Yes | 0.36 | 0.13 | 0.006 | 0.25 | 0.11 | 0.02 |
AFTN is for autonomously functioning thyroid nodules, PC is for predominantly cystic, and PS is for predominantly solid.